These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 18197627
21. A model for identifying HERG K+ channel blockers. Aronov AM, Goldman BB. Bioorg Med Chem; 2004 May 01; 12(9):2307-15. PubMed ID: 15080928 [Abstract] [Full Text] [Related]
22. Predictive models for hERG potassium channel blockers. Cianchetta G, Li Y, Kang J, Rampe D, Fravolini A, Cruciani G, Vaz RJ. Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3637-42. PubMed ID: 15978804 [Abstract] [Full Text] [Related]
23. [HERG K+ channel, the target of anti-arrhythmias drugs]. Guan FY, Yang SJ. Yao Xue Xue Bao; 2007 Jul 01; 42(7):687-91. PubMed ID: 17882949 [Abstract] [Full Text] [Related]
26. Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques. Garg D, Gandhi T, Gopi Mohan C. J Mol Graph Model; 2008 Feb 01; 26(6):966-76. PubMed ID: 17928249 [Abstract] [Full Text] [Related]
27. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage. Wang S, Li Y, Wang J, Chen L, Zhang L, Yu H, Hou T. Mol Pharm; 2012 Apr 02; 9(4):996-1010. PubMed ID: 22380484 [Abstract] [Full Text] [Related]
29. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current. Inanobe A, Kamiya N, Murakami S, Fukunishi Y, Nakamura H, Kurachi Y. J Physiol Sci; 2008 Dec 02; 58(7):459-70. PubMed ID: 19032804 [Abstract] [Full Text] [Related]
30. Predictive in silico modeling for hERG channel blockers. Aronov AM. Drug Discov Today; 2005 Jan 15; 10(2):149-55. PubMed ID: 15718164 [Abstract] [Full Text] [Related]
31. In silico prediction of hERG inhibition. Jing Y, Easter A, Peters D, Kim N, Enyedy IJ. Future Med Chem; 2015 Jan 15; 7(5):571-86. PubMed ID: 25921399 [Abstract] [Full Text] [Related]
32. Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers. Zachariae U, Giordanetto F, Leach AG. J Med Chem; 2009 Jul 23; 52(14):4266-76. PubMed ID: 19534531 [Abstract] [Full Text] [Related]
34. Computational investigations of hERG channel blockers: New insights and current predictive models. Villoutreix BO, Taboureau O. Adv Drug Deliv Rev; 2015 Jun 23; 86():72-82. PubMed ID: 25770776 [Abstract] [Full Text] [Related]
35. Quantitative structure-activity relationship models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the human ether-a-go-go-related gene potassium channel inhibition. Coi A, Massarelli I, Saraceno M, Carli N, Testai L, Calderone V, Bianucci AM. Chem Biol Drug Des; 2009 Oct 23; 74(4):416-33. PubMed ID: 19751420 [Abstract] [Full Text] [Related]
36. Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties. Polak S, Wiśniowska B, Brandys J. J Appl Toxicol; 2009 Apr 23; 29(3):183-206. PubMed ID: 18988205 [Abstract] [Full Text] [Related]
37. In silico classification of HERG channel blockers: a knowledge-based strategy. Dubus E, Ijjaali I, Petitet F, Michel A. ChemMedChem; 2006 Jun 23; 1(6):622-30. PubMed ID: 16892402 [Abstract] [Full Text] [Related]